Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting.
Maryza Graham,Stephen Muhi,Tuyet Hoang,Susan A Ballard,Julie L. McAuley,Jason C Kwong,Deborah A Williamson,Benjamin P Howden +7 more
Reads0
Chats0
About:
This article is published in Pathology.The article was published on 2021-09-04 and is currently open access. It has received 5 citations till now.read more
Citations
More filters
Journal ArticleDOI
Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings.
Prakash Ghosh,Rajashree Chowdhury,Mohammad Enayet Hossain,Faria Hossain,Mojnu Miah,Md. Utba Rashid,James Baker,Mohammed Ziaur Rahman,Mustafizur Rahman,Xuejun Ma,Malcolm S. Duthie,Ahmed Abd El Wahed,Dinesh Mondal +12 more
TL;DR: In this article, two recombinase-based isothermal techniques, reverse transcription recombinases polymerase amplification (RT-RPA) and reverse transcription aided amplification (RAA), were evaluated for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinical samples.
Journal ArticleDOI
Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings
TL;DR: In this article , two recombinase-based isothermal techniques, reverse transcription recombinases polymerase amplification (RT-RPA) and reverse transcription aided amplification (RAA), were evaluated for the detection of SARS-CoV-2 in clinical samples.
Journal ArticleDOI
Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions
James R. Barnacle,Hilda B. Houston,Ioannis Baltas,Junko Takata,K. Kavallieros,Niall Vaughan,Amit K. Amin,Sayeed Adnan Aali,Kara Beth Moore,P. Milner,A. Gupta Wright,Lusiba John +11 more
TL;DR: In this paper , the ID NOW near-patient test was used to identify patients at risk of having coronavirus disease 2019 (COVID-19) in the emergency department (ED) to ensure prompt treatment and maintain patient flow whilst minimizing nosocomial spread.
Journal ArticleDOI
Point of care molecular and antigen detection tests for COVID-19: current status and future prospects
TL;DR: Current knowledge on the utility of POCT NAATs and RATs for SARS-CoV-2 are reviewed and discussed alongside aspects of quality assurance factors that must be considered for successful and safe implementation ofPOCT.
Journal ArticleDOI
Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
TL;DR: In this paper , a review summarizes the point-of-care testing platforms developed by nucleic acid detection, immunological detection, and nanomaterial-based biosensors detection.
References
More filters
Journal ArticleDOI
Rethinking Covid-19 Test Sensitivity - A Strategy for Containment.
TL;DR: A simple point-of-care test that is inexpensive enough to use frequently, even if it lacks sensitivity, is proposed for Covid-19 cases.
Journal ArticleDOI
Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study.
Mirjam Kretzschmar,Ganna Rozhnova,Ganna Rozhnova,Martin C. J. Bootsma,Martin C. J. Bootsma,Michiel van Boven,Janneke van de Wijgert,Janneke van de Wijgert,Marc J. M. Bonten,Marc J. M. Bonten +9 more
TL;DR: The impact of timeliness and completeness in various steps of a contact tracing strategy is evaluated using a stochastic mathematical model with explicit time delays between time of infection and symptom onset and between symptom onset, diagnosis by testing, and isolation.
Journal ArticleDOI
Modelling transmission and control of the COVID-19 pandemic in Australia.
TL;DR: In this paper, the authors report the results of agent-based modelling using a fine-grained computational simulation of the ongoing COVID-19 pandemic in Australia, and compare several intervention strategies, including restrictions on international air travel, case isolation, home quarantine, social distancing with varying levels of compliance, and school closures.
Journal ArticleDOI
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.
Amanda T. Harrington,Brian Cox,Jennifer Snowdon,Jonathan Bakst,Erin Ley,Patricia Grajales,Jack A Maggiore,Stephen E. Kahn +7 more
TL;DR: The ID NOW COVID-19 (IDNCOV) assay performed on the ID Now Instrument is a rapid diagnostic test that can be performed in a point of care setting equivalent to CLIA waived testing.
Journal ArticleDOI
Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA.
Jean Y. H. Lee,Nickala Best,Julie L. McAuley,Jessica L. Porter,Torsten Seemann,Mark B. Schultz,Michelle Sait,Nicole Orlando,Karolina Mercoulia,Susan A Ballard,Julian Druce,Thomas Tran,Mike Catton,Melinda J. Pryor,Huanhuan L. Cui,Angela Luttick,Sean McDonald,Arran Greenhalgh,Jason C Kwong,Norelle L Sherry,Maryza Graham,Tuyet Hoang,Marion Herisse,Sacha J. Pidot,Deborah A Williamson,Benjamin P Howden,Ian R. Monk,Timothy P. Stinear +27 more
TL;DR: The N1 gene Single Tube Optigene LAMP assay (N1-STOP-LAMP) is a powerful, scalable option for specific and rapid detection of SARS-CoV-2 and an additional resource in the diagnostic armamentarium against COVID-19.